Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Xortx Therapeutics Inc (XRTX)

Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update GlobeNewswire - Wed Dec 31, 2025

CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Announces Closing of US$1.1 Million Registered Direct Offering GlobeNewswire - Wed Oct 29, 2025

CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering GlobeNewswire - Tue Oct 21, 2025

CALGARY, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency GlobeNewswire - Mon Oct 20, 2025

CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency GlobeNewswire - Mon Oct 20, 2025

CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems GlobeNewswire - Fri Oct 17, 2025

CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Initiates IND Preparation for XORLO™ in Gout Program GlobeNewswire - Wed Sep 3, 2025

CALGARY, Alberta, Sept. 03, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical...

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Provides Corporate Update and Planned Activities for 2025 / 2026 GlobeNewswire - Thu Aug 7, 2025

CALGARY, Alberta, Aug. 07, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Announces USD $3 Million Offering GlobeNewswire - Mon May 19, 2025

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)
XORTX Provides Update on FDA Type B Meeting Request GlobeNewswire - Wed Apr 30, 2025

XRTX.VN : 0.800 (+3.90%)
XRTX : 0.5700 (+1.42%)

Barchart Exclusives

CES 2026, Sector Rotation and Other Key Things to Watch this Week Barchart - Sun Jan 4, 12:00PM CST
Markets enter 2026's first full trading week with an extraordinary convergence of events including the Consumer Electronics Show (CES) in Las Vegas where Nvidia CEO Jensen Huang and AMD CEO Lisa Su will deliver keynote speeches that could significantly influence AI infrastructure investment narratives Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot